9 Criteria for Choosing a Medical Device Agency

Last Updated: 7/20/2026

Selecting a medical device marketing agency involves more than reviewing portfolios and checking references. You need a partner who understands FDA promotional guidelines, speaks the language of hospital procurement committees, and can reach surgeons, interventional cardiologists, and clinical evaluators where they actually research and decide.

Table of contents

• Quick guide: 9 criteria for evaluating medical device marketing agencies
• How we developed these evaluation criteria
• The 9 criteria for choosing a medical device marketing agency
• Comparison table: medical device agency evaluation criteria
• What questions should you ask during agency evaluation?
• How do evaluation criteria differ for early-stage versus established devices?
• Where XDS fits in this evaluation
• FAQs about choosing a medical device marketing agency
• Related reading from XDS

Quick guide: 9 criteria for evaluating medical device marketing agencies

XDS helps MedTech marketing teams navigate this evaluation process through strategy, design, and technology built for regulated industries. This guide breaks down nine criteria that matter most for regulatory content, hospital buyer alignment, and omnichannel growth. For a broader framework spanning pharma and biotech, see our companion guide on how to choose a healthcare marketing agency.

1. Regulatory content expertise: The agency creates FDA-ready promotional materials and understands OPDP submission requirements
2. Hospital buyer targeting capability: Experience reaching procurement committees, value analysis teams, and clinical stakeholders
3. Omnichannel execution: Integrated campaigns spanning digital, congress marketing, email, and sales enablement
4. HCP engagement strategy: Proven methods for reaching surgeons, specialists, and clinical decision-makers
5. CRM and marketing automation: Lead tracking and nurturing through complex B2B buying cycles
6. Measurement and attribution: Clear connection between marketing activities and pipeline outcomes
7. Content production at scale: Capacity to produce compliant content across channels without bottlenecks
8. AI and emerging technology: Modern tools for content structuring, personalization, and analytics
9. Life sciences focus: Dedicated healthcare expertise rather than generalist capabilities

How we developed these evaluation criteria

These criteria emerged from patterns we have observed across MedTech marketing engagements. Agencies that succeed share certain characteristics: every piece of content passes medical-legal review, they reach hospital buyers through multiple touchpoints, and they measure success in qualified leads and pipeline contribution, not vanity metrics. The same logic applies to biotech consulting, covered in our related breakdown on how to choose a biotech digital strategy consulting partner.

• Regulatory alignment: Does the agency build compliance into the creative process from day one?
• Audience depth: Can they create content that resonates with clinical evaluators and procurement teams?
• Technical infrastructure: Do they have CRM integration and analytics capabilities for complex sales cycles?
• Industry commitment: Is healthcare their focus, or one of many verticals they serve?
• Scalability: Can they produce the volume of content you need without sacrificing quality?
• Measurement rigor: Do they connect marketing spend to revenue outcomes you can defend to leadership?

If you are building a broader marketing plan alongside this agency search, our medical device marketing strategy guide covers the groundwork most agencies expect during onboarding.

The 9 criteria for choosing a medical device marketing agency

1. Regulatory content expertise: The foundation of MedTech marketing

Every promotional asset your agency produces must pass FDA guidelines and your internal medical-legal-regulatory review. An agency without regulatory content expertise creates materials that get rejected, delayed, or require extensive rework. You end up paying twice: once for the original work and again for corrections.

Look for agencies that structure content for compliance from the start, including fair balance requirements, claim substantiation with approved data, and formatting that streamlines MLR review rather than creating bottlenecks. XDS brings regulatory content development expertise that reduces back-and-forth during review cycles, creating promotional materials structured for FDA compliance while still engaging HCPs and procurement teams effectively.

Regulatory content expertise indicators

• Creates promotional materials structured for FDA compliance and MLR review efficiency
• Demonstrates understanding of fair balance requirements across digital and print channels
• Shows experience with 510(k) and PMA pathway marketing considerations

Regulatory content expertise pros and cons

Pros: Reduces MLR review cycles, lowers FDA warning letter risk, and creates reusable compliance frameworks.

Cons: Regulatory specialists may run smaller creative teams, need more upfront planning, and charge higher rates than generalists.

2. Hospital buyer targeting: Reaching procurement committees and value analysis teams

Medical device sales cycles involve multiple stakeholders. Clinical champions evaluate products on patient outcomes and ease of use. Procurement committees focus on cost, contracts, and vendor relationships. Value analysis teams weigh total cost of ownership against clinical benefits. Your agency needs strategies for each audience, including the physician side covered in our post on why device marketing misses specialist physicians.

Effective hospital buyer targeting goes beyond generic B2B marketing. It requires understanding how Integrated Delivery Networks make purchasing decisions, what evidence resonates with committee members, and how to support your sales team through extended evaluation periods.

Hospital buyer targeting indicators

• Demonstrates experience creating content for procurement committees and value analysis teams
• Produces ROI calculators, economic evidence summaries, and clinical outcome documentation

Hospital buyer targeting pros and cons

Pros: Addresses the complete buying committee, supports reps through multi-month evaluations, and differentiates your device with economic evidence.

Cons: Requires more research and production time, varies by institution size and structure, and often needs your own clinical and financial data.

3. Omnichannel execution: Coordinated campaigns across every touchpoint

HCPs engage with medical device information through multiple channels: online research, medical conferences, vendor emails, and sales interactions. An agency that only handles one channel leaves gaps in your customer journey.

According to McKinsey research, physicians increasingly prefer hybrid engagement models combining digital and in-person interactions. The share preferring video calls for sales interactions rose from 7 percent before 2020 to 38 percent today. Your agency should orchestrate these channels, not treat them as separate silos.

Omnichannel execution indicators

• Builds integrated programs across web, email, paid media, and congress marketing
• Tracks engagement across touchpoints to understand the complete customer journey

Omnichannel execution pros and cons

Pros: Reaches HCPs wherever they engage, keeps the brand experience consistent, and enables full-journey attribution rather than last-touch only.

Cons: Requires larger budgets, adds coordination complexity, and needs an integrated technology stack for full attribution.

4. HCP engagement strategy: Reaching clinical decision-makers effectively

Surgeons, interventional cardiologists, and other specialists evaluate medical devices differently than they evaluate other business purchases. They want clinical evidence, peer perspectives, and hands-on experience. Your agency needs strategies that respect their time while delivering what they need to decide confidently.

Effective HCP engagement combines educational content, KOL perspectives, and clinical evaluation opportunities. The agency should know which channels work for different specialties and how to move physicians from awareness through evaluation to advocacy. XDS builds HCP engagement programs that balance scientific depth with practical application for clinical audiences.

HCP engagement strategy indicators

• Creates educational content appropriate for specialist physician audiences
• Develops KOL engagement programs that amplify peer credibility
• Designs digital experiences optimized for time-constrained clinical professionals

HCP engagement strategy pros and cons

Pros: Builds credibility through evidence-based content, supports the clinical evaluation process, and creates peer-to-peer connections that extend adoption.

Cons: Requires medical writers with clinical expertise, KOL programs need relationship management beyond typical agency scope, and impact on sales takes longer to measure.

5. CRM and marketing automation: Tracking leads through complex buying cycles

Medical device sales cycles often span six to eighteen months, with multiple stakeholders engaging at different stages. Without proper CRM integration and marketing automation, you lose visibility into how marketing influences pipeline progression. Your agency should help build infrastructure that tracks leads from first touch through closed deal.

XDS delivers CRM strategy and implementation that helps MedTech teams create connected experiences across digital touchpoints, integrating patient and HCP engagement tools with broader marketing systems for unified visibility. AI is increasingly part of that infrastructure, as covered in our overview of AI sales enablement for healthcare and medtech.

CRM and marketing automation indicators

• Implements lead scoring models appropriate for B2B healthcare sales cycles
• Integrates marketing automation with sales tools and CRM systems

CRM and marketing automation pros and cons

Pros: Connects marketing to pipeline and revenue outcomes, automates nurturing, and shows which campaigns drive qualified opportunities.

Cons: Requires investment in technology and change management, and lead scoring needs ongoing refinement based on real conversion data.

6. Measurement and attribution: Connecting marketing spend to revenue

MedTech marketing leaders face increasing pressure to demonstrate return on investment. Website traffic and email opens do not satisfy executive questions about marketing's contribution to revenue. Your agency should help you build attribution models using leading indicators, such as evaluation requests or demo attendance, alongside lagging indicators that confirm revenue impact.

Measurement and attribution indicators

• Defines KPIs that connect marketing activities to pipeline and revenue outcomes
• Implements multi-touch attribution appropriate for long B2B sales cycles

Measurement and attribution pros and cons

Pros: Enables data-driven investment decisions, defends budgets in executive conversations, and identifies where to invest more.

Cons: Requires data integration across systems, and long sales cycles mean insights can lag execution by months.

7. Content production at scale: Meeting the demands of omnichannel marketing

Omnichannel marketing requires significant content volume: website pages, blog posts, email sequences, social content, sales enablement materials, and congress collateral. An agency that cannot produce at scale becomes a bottleneck that limits your marketing velocity.

Content production for medical devices adds complexity because every asset must maintain regulatory compliance. The agency needs processes that balance speed with accuracy, ensuring high volume does not compromise quality or create compliance risk. This is one of the most common places engagements go wrong, as detailed in our review of common medical device marketing mistakes in 2026.

Content production indicators

• Demonstrates capacity to produce compliant content across multiple channels simultaneously
• Employs medical writers with healthcare and life sciences expertise

Content production pros and cons

Pros: Removes content bottlenecks, keeps messaging consistent across touchpoints, and supports rapid response to market developments.

Cons: Requires larger agency teams and higher retainers, and scale can strain MLR review capacity without careful planning.

8. AI and emerging technology: Modern tools for regulated marketing

AI is changing how marketing agencies work. Modern tools accelerate content drafting, improve personalization, and enhance analytics. For MedTech marketing, the question is whether agencies apply these tools responsibly within regulatory constraints.

XDS embeds AI into real-world workflows to help clients gain competitive advantage, including AI-powered content structuring and analytics that surface insights from complex data sets, with human oversight ensuring outputs meet compliance requirements. Ask any agency how they think about visibility in AI-generated answers, not just traditional search, a shift our primer on answer engine optimization for healthcare explains in more detail.

AI and technology indicators

• Uses AI tools to accelerate content production while maintaining human oversight
• Applies AI governance practices appropriate for regulated content
• Structures content for visibility in AI search platforms and generative engines

AI and technology pros and cons

Pros: Accelerates content production, enables personalization at scale, and positions content for visibility as HCPs use AI search tools.

Cons: Requires careful review for accuracy and compliance, and evolving capabilities demand ongoing evaluation.

9. Life sciences focus: Dedicated healthcare expertise matters

Generalist agencies spread their attention across industries, consumer goods one week and healthcare the next. This dilutes their expertise and means your team spends time educating them about basics they should already know.

XDS focuses exclusively on healthcare and life sciences with specialized teams for biotech, pharma, and MedTech. This focus means the team already understands your regulatory environment, audience expectations, and competitive dynamics. You spend time on strategy, not education.

Life sciences focus indicators

• Demonstrates portfolio concentrated in healthcare, biotech, pharma, and MedTech
• Shows thought leadership and ongoing investment in life sciences marketing knowledge

Life sciences focus pros and cons

Pros: Eliminates ramp-up time on industry basics, brings relevant case studies and benchmarks, and stays current on regulatory changes.

Cons: May run smaller overall teams than global networks, and specialized expertise commands rates that reflect industry knowledge.

Comparison table: Medical device agency evaluation criteria

If you want to see how a broader set of MedTech-focused shops stack up against each other rather than against generalists, our companion piece on the top medical device marketing agencies for 2026 profiles specific firms side by side.

What questions should you ask during agency evaluation?

Start by asking how the agency handles regulatory compliance. Request specific examples of FDA-compliant campaigns they have executed, and ask how they structure content for MLR review efficiency and what happens when materials need revision.

Dig into their process for reaching hospital buyers. Can they explain how they have helped other MedTech companies engage procurement committees and value analysis teams, including ROI calculators and economic evidence summaries? Ask about important safety information placement too, since agencies unfamiliar with the space often get this wrong. See our guide on important safety information best practices.

Finally, ask about measurement. How do they connect marketing activities to pipeline outcomes, and what leading indicators do they track for medical device campaigns? Request attribution reporting examples, ideally benchmarked against the methodology questions in our healthcare marketing attribution guide.

How do evaluation criteria differ for early-stage versus established devices?

Early-stage device companies preparing for market entry should prioritize regulatory content expertise and market positioning. You need an agency that can help build foundational messaging, create launch materials, and establish your brand. Omnichannel sophistication matters less while you are still defining your core value proposition.

Established device companies should prioritize omnichannel execution, measurement infrastructure, and content production at scale. You already have regulatory content processes; now you need a partner who can reach more HCPs, support your sales team through complex evaluations, and demonstrate marketing ROI to leadership. Either way, benchmarking your program against common failure patterns in our post on medical device marketing mistakes in 2026 is a useful step before interviews.

Where XDS fits in this evaluation

XDS combines regulatory expertise, omnichannel capabilities, and modern technology under one roof. Many agencies specialize in one area of this list, or spread their attention across unrelated industries. XDS focuses exclusively on healthcare and life sciences, with the capabilities to execute from strategy through measurement, including CRM platforms like Veeva that many MedTech teams already rely on.

The combination of AI-driven content structuring with deep regulatory knowledge addresses one of the biggest challenges in medical device marketing: creating compliant content at the speed modern campaigns require while staying visible as HCPs increasingly use AI-powered research tools.

For MedTech companies evaluating agency partners, XDS brings the regulatory expertise, hospital buyer targeting capabilities, and measurement discipline you need. Connect with XDS to discuss how we can support your commercial goals.

FAQs about choosing a medical device marketing agency

What regulatory expertise should a medical device marketing agency have?

Your agency should understand FDA promotional guidelines, fair balance requirements, and OPDP submission processes. XDS creates promotional materials structured for FDA compliance and MLR review efficiency. Ask potential agencies to explain how they handle claim substantiation and what their process looks like for ensuring regulatory accuracy across digital and print channels.

How do you evaluate an agency's hospital buyer targeting capabilities?

Ask for case studies showing how the agency has reached procurement committees and value analysis teams. Look for experience creating ROI calculators, economic evidence summaries, and sales enablement materials. XDS helps MedTech companies address the complete buying committee through content that speaks to clinical, financial, and operational stakeholders.

Why does omnichannel execution matter for medical device marketing?

Healthcare professionals engage with vendor information through multiple channels, from websites and email to conferences and sales interactions. XDS builds integrated programs that coordinate messaging across touchpoints. This omnichannel approach ensures consistent brand experience and enables attribution across the full customer journey rather than isolated channel metrics.

How should you assess an agency's measurement capabilities?

Request examples of attribution reporting from comparable MedTech engagements. Ask what leading indicators they track for medical device campaigns and how they connect marketing activities to pipeline outcomes. XDS implements measurement infrastructure that provides actionable visibility for marketing and sales leadership through dashboards that track meaningful business metrics.

What role does AI play in modern medical device marketing?

AI accelerates content production, improves personalization, and enhances analytics capabilities. XDS embeds AI into workflows while maintaining human oversight for regulatory compliance. Ask potential agencies about their AI governance practices and how they ensure AI-generated content meets FDA guidelines and brand standards.

Related reading from XDS

These companion posts go deeper on individual criteria covered above:

• Top medical device marketing agencies for 2026
• How to choose a healthcare marketing agency
• How to choose a biotech digital strategy consulting partner
• Medical device marketing strategy: the complete guide
• 7 reasons device marketing misses specialist physicians
• 7 medical device marketing mistakes in 2026
• Fair balance in pharma advertising: rules and examples
• Important safety information best practices for healthcare
• Healthcare marketing attribution and measurement guide
• AI sales enablement for healthcare, pharma, and medtech
• Pharma SEO in 2026
• What is AEO? Answer engine optimization for healthcare

If you are ready to talk through your own agency search, connect with XDS and we will walk through how these criteria apply to your specific device category and stage of growth.